Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA

Journal of Clinical Pathology

Volumn 52, Issue 11, 1999, Pages 807-811

  Yu, Ming Lung ^a   Chuang, Wan Long ^a   Chen, Shinn Cherng ^a   Lin, Zu Yau ^a   Hsieh, Ming Yuh ^a   Wang, Liang Yen ^a   Chang, Wen Yu ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hepatitis C virus; Interferon; Virus quantification assay

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA ANALYSIS; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0032745425     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.11.807     Document Type: Article

References (23)

1. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
2. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
3. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
4. Kato N, Yokosuka O, Hosoda K, et al. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993;18:16-20.
5. Hayashi J, Kishihara Y, Yoshimura E, et al. Relationship of genotype to level of hepatitis C viremia determined by competitive polymerase chain reaction. J Infect 1995;30:235-9.
6. Hagiwara H, Hayashi N, Mita E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993;104:877-83.
7. Toyoda H, Nakano S, Kumada T, et al. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-α therapy in chronic hepatitis C patients. J Med Virol 1996;48;354-9.
8. Trabaud MA, Bailly F, Si-Ahmed SN, et al. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. J Med Virol 1997;52:1-8.
9. Lau JYN, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-4.
10. Colucci G, Gutekunst K. Development of a quantitative PCR assay for monitoring HCV viremia levels in patients with chronic hepatitis C. J Viral Hepatitis 1997;4:75-8.
11. Detmer J, Lagier R, Flynn J, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotype by using branched-DNA technology. J Clin Microbiol 1996;34:901-7.
12. Yu ML, Chuang WL, Lu SN, et al. The genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection in Southern Taiwan. Kaohsiung J Med Sci 1996;12:605-12.
13. Okamoto H, Tokita H, Sakamoto M, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993;74:2385-90.
14. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
15. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1903;39:561-77.
16. Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol 1997;35:187-92.
17. Collins ML, Zayati C, Detmer JJ, et al. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem 1995;226:120-9.
18. Smith DB, Davidson F, Yap PL, et al. Levels of hepatitis C virus in blood donors infected with different viral genotypes. J Infect Dis 1996;173:727-30.
19. Lau JYN, Davis GL, Prescott LE, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann Intern Med 1996;124:868-76.
20. Lau JYN, Simmonds P. Urdea MS. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 1995;346:425-6.
21. Smith DB, Mellor J, Jarvis LM, et al. Variation of hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. J Gen Virol 1995;6:1749-61.
22. Dubois DB, Gretch D, Rosa CD, et al. Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender-related differences in viral load. Am J Kidney Dis 1994;24:795-801.
23. Reichard O, Norkrans G, Fryden A, et al. Randomised, double-blind, placebo-controlled trial of interferon u-2b with and without ribavirin for chronic hepatitis C. Lancet 1998;351:83-7.